The development of aortic valve sclerosis may signal disease progression in patients with chronic heart failure.

The following is a summary of “Postinterventional surveillance at a dedicated valve unit is safe and reduces intensive care ...

Aortyx SL secured €13.8 million (US$15.9 million) in a series A funding round for its solution which treats aortic dissection. The company developed a system to repair the aortic tear, which includes ...

Aortyx announced today that it brought in $16 million (€13.8 million) to support its bioresorbable aortic patch technology.